02.12.2024
Leadership Announcements and New Arcera Structure
Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving...
News
Growth
24.07.2024
Acino signs an exclusive agreement with LG Chem for Novel Treatments for Type 2 Diabetes and Osteoarthritis in Latin America
M8 Pharmaceuticals, an Acino company (“M8”), today announces the signature of an exclusive licensing and distribution agreement with LG Chem...
24.06.2024
Acino signs an exclusive licensing and supply agreement with Allecra Therapeutics in Gulf Cooperation Council countries and South Africa
The agreement focuses on the distribution of Allecra’s novel antibiotic drug EXBLIFEP® (cefepime/enmetazobactam) within the Republic of South Africa and...
07.05.2024
Acino signs an exclusive license agreement with Supernus in Latin America
M8 Pharmaceuticals, an Acino company (‘M8’) announces that the company has signed an exclusive licensing agreement with Supernus Pharmaceuticals, Inc....
02.04.2024
Acino announces new regional leadership and hub to deliver on expanded presence and capabilities in Latin America following M8 acquisition
Joel Barlan has been appointed as Head of the LATAM region. Mexico City will now serve as a regional hub...
20.03.2024
Acino signs an exclusive license agreement with SERB Pharmaceuticals in Latin America
M8 Pharmaceuticals, an Acino company (“M8”) and SERB Pharmaceuticals (“SERB”), a global specialty pharmaceutical company, are collaborating to bring an...
29.01.2024
Acino signs an exclusive distribution agreement with the Swedish biopharmaceutical company Sobi in Kazakhstan
The agreement focuses on the distribution of orphan drugs developed for patients with conditions such as rheumatoid arthritis, cryopyrin-associated periodic...
04.12.2023
Acino Completes Acquisition of M8 Pharmaceuticals Significantly Expanding Presence and Capabilities in Latin America
With nearly 300 new employees on board, Acino will enhance its presence in Latin America and strengthen its business through...
20.09.2023
Acino Significantly Expands Presence and Capabilities in Latin America Through Acquisition of M8 Pharmaceuticals
Over 300 M8 employees, product portfolio and pipeline to enhance Acino’s footprint and strategic position in key Latin American markets....